Stay Alert for Meds on the “KIDs List” to Keep Children Safe

January 2026

Improve your pediatric safety practices based on recent updates to the Key Potentially Inappropriate Drugs (KIDs) list.

This is the first revision since the initial KIDs list was published by the US Pediatric Pharmacy Association in 2020. Review notable changes to help improve pediatric care.

Additions. Be aware that montelukast is now on the list...it has a higher risk of sleep disturbances in kids under 18 versus adults.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Obesity & Weight Loss Listen for New Side Effect Concerns With GLP-1 Agonists
Pediatrics Be Aware of the Role of Jornay PM for ADHD
Hair Loss Untangle Mix-Ups With Meds for Male Pattern Baldness
Pediatrics Stay Alert for Meds on the “KIDs List” to Keep Children Safe
Biologics Be Familiar With the Laundry List of Uses for Dupilumab
Education and Training Weave AI Into Your Plan for Training Learners
Alzheimer Disease Know the Pros and Cons of Lecanemab for Alzheimer Disease
NatMed Spotlight Methylene Blue: Evidence Review

Stay Alert for Meds on the “KIDs List” to Keep Children Safe

Practical advice for a better career, with unlimited access to CE

Table of Contents